Literature DB >> 3328189

The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

M G Harrington1, P G Kennedy.   

Abstract

The clinical diagnosis of definite multiple sclerosis is supported by abnormalities in the cerebrospinal fluid: variable mild pleocytosis and elevation of total protein, moderately elevated total IgG in most patients, and the almost invariable presence of discrete immunoglobulins after electrophoresis, the oligoclonal bands. The oligoclonal bands are non-specific, and are seen in most diseases of the nervous system, but their temporal uniformity in each patient with multiple sclerosis is characteristic. Prognostically, patients with a single episode of optic neuritis or paraesthesia who have oligoclonal bands are more likely to develop multiple sclerosis than if the spinal fluid were normal. In the Guillain-Barré syndrome, the spinal fluid total protein is transiently elevated, with no pleocytosis. Oligoclonal bands are usually found in the acute phase and only persist in those patients with chronic or relapsing polyneuropathy.

Entities:  

Mesh:

Year:  1987        PMID: 3328189      PMCID: PMC2428544          DOI: 10.1136/pgmj.63.743.735

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  33 in total

1.  The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.

Authors:  D Moulin; D W Paty; G C Ebers
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

2.  Oligoclonal bands in CSF: twins with MS.

Authors:  X H Xu; D E McFarlin
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

3.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

4.  Isoelectric focusing of CSF proteins and the future evolution of multiple sclerosis: a clinical follow-up.

Authors:  B Ersmark; A Sidén
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

5.  Two-dimensional gel electrophoresis of cerebrospinal fluid proteins.

Authors:  D Goldman; C R Merril; M H Ebert
Journal:  Clin Chem       Date:  1980-08       Impact factor: 8.327

6.  Paraproteins in the spinal fluid of patients with paraproteinemic polyneuropathies.

Authors:  M C Dalakas; N M Papadopoulos
Journal:  Ann Neurol       Date:  1984-06       Impact factor: 10.422

7.  Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders.

Authors:  O G Segurado; H Krüger; H G Mertens
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

8.  Optic neuritis: oligoclonal bands increase the risk of multiple sclerosis.

Authors:  L Stendahl-Brodin; H Link
Journal:  Acta Neurol Scand       Date:  1983-05       Impact factor: 3.209

9.  Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases.

Authors:  A B Chu; J L Sever; D L Madden; M Iivanainen; M Leon; W Wallen; B R Brooks; Y J Lee; S Houff
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

10.  Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation.

Authors:  M A Farrell; J C Kaufmann; J J Gilbert; J H Noseworthy; H A Armstrong; G C Ebers
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.